Clinical Trials Logo

Clinical Trial Summary

Comparison between two diagnostic modalities for breast cancer diagnosis. Two different imaging systems are compared to evaluate the performance of the two systems


Clinical Trial Description

The diagnostic quality of MRI of the breast has made this method a gold standard in the imaging of senologic lesions. Low-dose dedicated breast CT (BCT) with single photon-detection (nu:view, developed by AB-CT - Advanced Breast-CT GmbH) has emerged as a fully 3D imaging modality that uses ionizing radiation comparable to 2D mammography and has its intended use in helping with diagnosis in diagnostic breast imaging. The investigation is designed as a prospective non-randomized intra-individual cohort procedure comparison between the imaging platforms, nu:view and MRI. Across 3 hospital-based study sites in two countries, study participants (patients who meet study criteria and have consented) sequentially receive nu:view imaging and, with a delay of up to one week (preferably on the same day), MRI imaging. At both times, patients receive contrast agent. Images generated from breasts are evaluated by three independent radiologists and their scores and interpretations are statistically evaluated. The research aim is to demonstrate non-inferiority of BCT compared with MRI in major indications of MRI for breast diagnostics. The perceived gain in the study is to generate data on clinical performance of the BCT device nu:view and on the procedure that could be supportive of a tailored use of nu:view in patients with major indications of MRI for breast diagnostics. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05989022
Study type Interventional
Source AB-CT - Advanced Breast-CT GmbH
Contact
Status Recruiting
Phase N/A
Start date November 24, 2023
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT01885741 - Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy N/A
Active, not recruiting NCT01956409 - Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis Phase 4
Recruiting NCT05858762 - Artificial Intelligence for Automated Diagnosis of Breast Cancer
Completed NCT02608281 - Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI N/A
Terminated NCT03863522 - Automated Method for Breast Cancer Detection N/A
Completed NCT01952717 - PMA Required Pivotal Multi-reader Multi-case Reader Study N/A
Recruiting NCT04429269 - A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis
Recruiting NCT02869607 - Institut Paoli Calmettes Breast Cancer Database N/A
Not yet recruiting NCT06185855 - A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in Ultrasonography